These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 20190806)
1. Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma. Ochiai H; Takenobu H; Nakagawa A; Yamaguchi Y; Kimura M; Ohira M; Okimoto Y; Fujimura Y; Koseki H; Kohno Y; Nakagawara A; Kamijo T Oncogene; 2010 May; 29(18):2681-90. PubMed ID: 20190806 [TBL] [Abstract][Full Text] [Related]
2. MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas. Huang R; Cheung NK; Vider J; Cheung IY; Gerald WL; Tickoo SK; Holland EC; Blasberg RG FASEB J; 2011 Dec; 25(12):4138-49. PubMed ID: 21856782 [TBL] [Abstract][Full Text] [Related]
3. BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas. Nowak K; Kerl K; Fehr D; Kramps C; Gessner C; Killmer K; Samans B; Berwanger B; Christiansen H; Lutz W Nucleic Acids Res; 2006; 34(6):1745-54. PubMed ID: 16582100 [TBL] [Abstract][Full Text] [Related]
4. GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3. Fabian J; Lodrini M; Oehme I; Schier MC; Thole TM; Hielscher T; Kopp-Schneider A; Opitz L; Capper D; von Deimling A; Wiegand I; Milde T; Mahlknecht U; Westermann F; Popanda O; Roels F; Hero B; Berthold F; Fischer M; Kulozik AE; Witt O; Deubzer HE Cancer Res; 2014 May; 74(9):2604-16. PubMed ID: 24419085 [TBL] [Abstract][Full Text] [Related]
5. Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation. Ando K; Ohira M; Ozaki T; Nakagawa A; Akazawa K; Suenaga Y; Nakamura Y; Koda T; Kamijo T; Murakami Y; Nakagawara A Int J Cancer; 2008 Nov; 123(9):2087-94. PubMed ID: 18726896 [TBL] [Abstract][Full Text] [Related]
6. The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma. Slack A; Chen Z; Tonelli R; Pule M; Hunt L; Pession A; Shohet JM Proc Natl Acad Sci U S A; 2005 Jan; 102(3):731-6. PubMed ID: 15644444 [TBL] [Abstract][Full Text] [Related]
7. Cyclin E1 is a common target of BMI1 and MYCN and a prognostic marker for neuroblastoma progression. Mao L; Ding J; Perdue A; Yang L; Zha Y; Ren M; Huang S; Cui H; Ding HF Oncogene; 2012 Aug; 31(33):3785-95. PubMed ID: 22120721 [TBL] [Abstract][Full Text] [Related]
8. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features. Tajiri T; Liu X; Thompson PM; Tanaka S; Suita S; Zhao H; Maris JM; Prendergast GC; Hogarty MD Clin Cancer Res; 2003 Aug; 9(9):3345-55. PubMed ID: 12960121 [TBL] [Abstract][Full Text] [Related]
9. MYCN is recruited to the RASSF1A promoter but is not critical for DNA hypermethylation in neuroblastoma. Charlet J; Szemes M; Malik KT; Brown KW Mol Carcinog; 2014 May; 53(5):413-20. PubMed ID: 23280764 [TBL] [Abstract][Full Text] [Related]
10. A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma. Shohet JM; Ghosh R; Coarfa C; Ludwig A; Benham AL; Chen Z; Patterson DM; Barbieri E; Mestdagh P; Sikorski DN; Milosavljevic A; Kim ES; Gunaratne PH Cancer Res; 2011 Jun; 71(11):3841-51. PubMed ID: 21498633 [TBL] [Abstract][Full Text] [Related]
11. N-Myc differentially regulates expression of MXI1 isoforms in neuroblastoma. Armstrong MB; Mody RJ; Ellis DC; Hill AB; Erichsen DA; Wechsler DS Neoplasia; 2013 Dec; 15(12):1363-70. PubMed ID: 24403858 [TBL] [Abstract][Full Text] [Related]
12. MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma. Manohar CF; Bray JA; Salwen HR; Madafiglio J; Cheng A; Flemming C; Marshall GM; Norris MD; Haber M; Cohn SL Oncogene; 2004 Jan; 23(3):753-62. PubMed ID: 14737110 [TBL] [Abstract][Full Text] [Related]
14. Bmi1 regulates cell fate via tumor suppressor WWOX repression in small-cell lung cancer cells. Kimura M; Takenobu H; Akita N; Nakazawa A; Ochiai H; Shimozato O; Fujimura Y; Koseki H; Yoshino I; Kimura H; Nakagawara A; Kamijo T Cancer Sci; 2011 May; 102(5):983-90. PubMed ID: 21276135 [TBL] [Abstract][Full Text] [Related]
15. CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression. Zhao X; Li D; Pu J; Mei H; Yang D; Xiang X; Qu H; Huang K; Zheng L; Tong Q Oncogene; 2016 Jul; 35(27):3565-76. PubMed ID: 26549029 [TBL] [Abstract][Full Text] [Related]
16. Cellular retinoic acid-binding protein II is a direct transcriptional target of MycN in neuroblastoma. Gupta A; Williams BR; Hanash SM; Rawwas J Cancer Res; 2006 Aug; 66(16):8100-8. PubMed ID: 16912187 [TBL] [Abstract][Full Text] [Related]
17. Calreticulin regulates MYCN expression to control neuronal differentiation and stemness of neuroblastoma. Lee AC; Shih YY; Zhou F; Chao TC; Lee H; Liao YF; Hsu WM; Hong JH J Mol Med (Berl); 2019 Mar; 97(3):325-339. PubMed ID: 30612140 [TBL] [Abstract][Full Text] [Related]